Drugs A-Z
Complete pharmaceutical drug database with pharmacological properties and clinical data.
Browse the pages below for detailed information.
IDE397
IDE397. Synthetic organic pharmaceutical agent.
idelalisib
idelalisib. Synthetic organic pharmaceutical agent.
IDR-1
IDR-1. Peptide pharmaceutical agent.
IDRA-21
IDRA-21. Synthetic organic pharmaceutical agent.
idremcinal
idremcinal. Synthetic organic pharmaceutical agent.
ifebemtinib
ifebemtinib. Synthetic organic pharmaceutical agent.
ifenprodil
ifenprodil. Synthetic organic pharmaceutical agent.
ifetroban
ifetroban. Synthetic organic pharmaceutical agent.
ifidancitinib
ifidancitinib. Synthetic organic pharmaceutical agent.
ifinatamab deruxtecan
ifinatamab deruxtecan. Antibody pharmaceutical agent.
IFN-α1/13
IFN-α1/13. Peptide pharmaceutical agent.
IFN-α10
IFN-α10. Peptide pharmaceutical agent.
IFN-α14
IFN-α14. Peptide pharmaceutical agent.
IFN-α16
IFN-α16. Peptide pharmaceutical agent.
IFN-α17
IFN-α17. Peptide pharmaceutical agent.
IFN-α2
IFN-α2. Peptide pharmaceutical agent.
IFN-α21
IFN-α21. Peptide pharmaceutical agent.
IFN-α2b (recombinant human)
IFN-α2b (recombinant human). Peptide pharmaceutical agent.
IFN-α4
IFN-α4. Peptide pharmaceutical agent.
IFN-α5
IFN-α5. Peptide pharmaceutical agent.
IFN-α6
IFN-α6. Peptide pharmaceutical agent.
IFN-α7
IFN-α7. Peptide pharmaceutical agent.
IFN-α8
IFN-α8. Peptide pharmaceutical agent.
IFN-β
IFN-β. Peptide pharmaceutical agent.
IFN-β1a (recombinant human)
IFN-β1a (recombinant human). Peptide pharmaceutical agent.
IFN-β1b (recombinant human)
IFN-β1b (recombinant human). Peptide pharmaceutical agent.
IFN-γ
IFN-γ. Peptide pharmaceutical agent.
IFN-γ1b (human recombinant)
IFN-γ1b (human recombinant). Peptide pharmaceutical agent.
IFN-κ
IFN-κ. Peptide pharmaceutical agent.
IFN-λ1
IFN-λ1. Peptide pharmaceutical agent.
IFN-λ2
IFN-λ2. Peptide pharmaceutical agent.
IFN-λ3
IFN-λ3. Peptide pharmaceutical agent.
IFN-ω
IFN-ω. Peptide pharmaceutical agent.
ifosfamide
ifosfamide. Synthetic organic pharmaceutical agent.
ifupinostat
ifupinostat. Synthetic organic pharmaceutical agent.
IgE heavy chain
IgE heavy chain. Peptide pharmaceutical agent.
IGN523
IGN523. Antibody pharmaceutical agent.
iguratimod
iguratimod. Synthetic organic pharmaceutical agent.
IHMT-MST1-58
IHMT-MST1-58. Synthetic organic pharmaceutical agent.
IIK7
IIK7. Synthetic organic pharmaceutical agent.
IK-862
IK-862. Synthetic organic pharmaceutical agent.
IKK-2 inhibitor IV
IKK-2 inhibitor IV. Synthetic organic pharmaceutical agent.
IKK-beta inhibitor R-28
IKK-beta inhibitor R-28. Synthetic organic pharmaceutical agent.
IKs124
IKs124. Synthetic organic pharmaceutical agent.
IL-1 receptor antagonist
IL-1 receptor antagonist. Peptide pharmaceutical agent.
IL-1α
IL-1α. Peptide pharmaceutical agent.
IL-1β
IL-1β. Peptide pharmaceutical agent.
IL-10
IL-10. Peptide pharmaceutical agent.
IL-11
IL-11. Peptide pharmaceutical agent.
IL-12
IL-12. Peptide pharmaceutical agent.
IL-12A
IL-12A. Peptide pharmaceutical agent.
IL-12B
IL-12B. Peptide pharmaceutical agent.
IL-13
IL-13. Peptide pharmaceutical agent.
IL-15
IL-15. Peptide pharmaceutical agent.
IL-17A
IL-17A. Peptide pharmaceutical agent.
IL-17A/IL-17F
IL-17A/IL-17F. Peptide pharmaceutical agent.
IL-17B
IL-17B. Peptide pharmaceutical agent.
IL-17C
IL-17C. Peptide pharmaceutical agent.
IL-17F
IL-17F. Peptide pharmaceutical agent.
IL-18
IL-18. Peptide pharmaceutical agent.